Clinical Trial Update: Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating remifentanil plus ketamine for dynamic flexible bronchoscopy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchoscopy

Drugs mentioned

• Ketamine (ketamine)
• Remifentanil (remifentanil)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Bronchoscopy | Phase 4 | Status: WITHDRAWN